Urologists should maintain a high level of suspicion of cystinuria in young patients (<30 years old) who have recurrent stone disease or siblings with stone disease Patients with cystinuria require ...

The goal of therapy is to reduce urinary cystine concentration below its solubility limit. Venxxiva ™ (tiopronin delayed-release tablet) has been made available for the treatment of cystinuria.

Cystine stones are a type of kidney stone. They are also called renal calculi, nephrolithiasis, or urolithiasis, and they are caused by a genetic condition. Here’s what to know about cystine crystals ...

BOSTON, March 18, 2025--(BUSINESS WIRE)--Cycle Pharmaceuticals Limited (Cycle) announced today the launch of VENXXIVA (tiopronin) Delayed-Release Tablets, for the treatment of cystinuria, approved by ...

Cystinuria is an inherited disorder in which defective amino acid reabsorption in the kidney causes over-excretion of cystine and dibasic amino acids into urine. Since cystine tends to crystallize in ...

Cystinuria is an inherited genetic condition that involves changes in the extent of reabsorption of cystine and other dibasic acids from the urine and into the bloodstream. As a result, affected ...

Cystinuria is a chronic condition that cannot be cured. However, certain management techniques can help to prevent the formation of stones in the kidneys and their resulting complications. Firstly, it ...

The US Food and Drug Administration (FDA) has approved an enteric-coated delayed-release formulation of tiopronin (Thiola EC, Retrophin) for treatment of cystinuria, a rare inherited disorder that ...

PARIS, January 29, 2025--(BUSINESS WIRE)--Regulatory News: Advicenne (Euronext Growth Paris ALDVI – FR0013296746) a specialty pharmaceutical company dedicated to the development and commercialization ...

A rare condition in which stones made from an amino acid called cystine form in the kidney, ureter and bladder is known as cystinuria. This condition can be passed down through generations. A person ...